Literature DB >> 25311631

SPARC is associated with carcinogenesis of oral squamous epithelium and consistent with cell competition.

Tomohiro Yamada1, Seiji Ohno2, Naoya Kitamura2, Eri Sasabe2, Tetsuya Yamamoto2.   

Abstract

The matricellular protein, secreted protein acidic and rich in cysteine (SPARC) is thought to be involved in cell competition. The objective of this study is to investigate the role of SPARC in cancerization of oral squamous epithelium. Clinical specimens from 57 pre- and early cancerous lesion, 66 invasive squamous cell carcinoma (SCC) and controls were immunostained with SPARC. Clinical features and SPARC expression were evaluated. Furthermore, effects of SPARC knockdown and overexpression were examined in oral cancer and keratinocyte cell lines. Leukoplakia, carcinoma in situ, and early invasive SCC had more SPARC-positive cells than normal mucous epithelium. However, there were no significant differences between leukoplakia, carcinoma in situ, and early SCC, and there were no correlations between SPARC immunoreactivity and prognosis of invasive oral SCCs. Cell proliferation was down-regulated by SPARC siRNA, and enhanced by SPARC transformed keratinocytes. But SPARC overexpression did not enhance cell migration activity. SPARC is induced by dysplastic cells in the early stage of cancerization, and may improve survival capability, but is not involved in malignancy. SPARC may act to escape from elimination by cell competition.

Entities:  

Keywords:  Carcinogenesis; Dysplasia; Leukoplakia; Oral cancer; SPARC

Mesh:

Substances:

Year:  2014        PMID: 25311631     DOI: 10.1007/s00795-014-0089-5

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  28 in total

1.  Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 cases.

Authors:  Yasumasa Kato; Yoji Nagashima; Yuh Baba; Toshiro Kawano; Madoka Furukawa; Akira Kubota; Shunsuke Yanoma; Yukari Imagawa-Ishiguro; Kenichi Satake; Takahide Taguchi; Ryu-Ichiro Hata; Izumi Mochimatsu; Ichiro Aoki; Yoichi Kameda; Yoshiaki Inayama; Mamoru Tsukuda
Journal:  Int J Mol Med       Date:  2005-08       Impact factor: 4.101

2.  Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas.

Authors:  D Massi; A Franchi; L Borgognoni; U M Reali; M Santucci
Journal:  Hum Pathol       Date:  1999-03       Impact factor: 3.466

Review 3.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

4.  SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42.

Authors:  Praveen Bhoopathi; Christopher S Gondi; Meena Gujrati; Dzung H Dinh; Sajani S Lakka
Journal:  Cell Signal       Date:  2011-07-23       Impact factor: 4.315

5.  SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.

Authors:  G K Yiu; W Y Chan; S W Ng; P S Chan; K K Cheung; R S Berkowitz; S C Mok
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma.

Authors:  Martin Grimm; Michael Krimmel; Joachim Polligkeit; Dorothea Alexander; Adelheid Munz; Susanne Kluba; Constanze Keutel; Jürgen Hoffmann; Siegmar Reinert; Sebastian Hoefert
Journal:  Eur J Cancer       Date:  2012-07-10       Impact factor: 9.162

7.  Drosophila SPARC is a self-protective signal expressed by loser cells during cell competition.

Authors:  Marta Portela; Sergio Casas-Tinto; Christa Rhiner; Jesús M López-Gay; Orlando Domínguez; Davide Soldini; Eduardo Moreno
Journal:  Dev Cell       Date:  2010-10-19       Impact factor: 12.270

8.  Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Rolf A Brekken; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris; E Helene Sage
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

Review 9.  Super competition as a possible mechanism to pioneer precancerous fields.

Authors:  Christa Rhiner; Eduardo Moreno
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

10.  Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

Authors:  A Bergamaschi; E Tagliabue; T Sørlie; B Naume; T Triulzi; R Orlandi; H G Russnes; J M Nesland; R Tammi; P Auvinen; V-M Kosma; S Ménard; A-L Børresen-Dale
Journal:  J Pathol       Date:  2008-02       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.